Skip to main content
US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives
User login
Username
Password
Reset your password
Concept
Lead
score
Biologic Therapy
1
1
Biosimilars
0
0.99
Revenue and Practice Management
0
0.48
Medicare
0
0.43
Insurance
0
0.39
Medicaid
0
0.39
Electronic Health Record (EHR)
0
0.33
Arthritis
0
0.09
Grant
0
0.09
Specialty
Lead
score
Rheumatology
1
1
Pharmacist
0
0.7
Family Medicine/Primary Care
0
0.8
Internal Medicine
0
0.9
Edit Tags